ASX:PKYSoftware & ServicesApplication Software
PATHKEY.AI ORD
$0.040
$0.001 (2.44%)
Day Range
$0.040 - $0.046
52 Week Range
$0.013 - $0.071
Volume
6.75M
Avg Volume (10D)
4.54M
Market Cap
$24.28M
Price Chart
Market Statistics
Open$0.041
Previous Close$0.041
Day High$0.046
Day Low$0.040
52 Week High$0.071
52 Week Low$0.013
Valuation
Market Cap24.28M
Shares Outstanding607.08M
Price to Book27.00
Trading Activity
Volume6.75M
Value Traded279.98K
Bid$0.040 × 5,364
Ask$0.044 × 75,000
Performance
1 Day-2.44%
5 Day-24.53%
13 Week100.00%
52 Week93.18%
YTD150.00%
Technical Indicators
RSI (14)50.73
50-Day SMA$0.031
200-Day SMA$0.023
Latest News
Technology
Pathkey.AI Moves to Add Semiconductor Design Platform through Chipforge Acquisition
Pathkey.AI to acquire Chipforge, expanding AI into semiconductor design; irrevocable option to buy 100% within 2 months, via 560 million Pathkey shares.
2 min read
Technology
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
1 min read
Technology
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported that TrialKey correctly aligned with 73% of trial outcomes across 11 clinical programs that reported results between March and July 2025. Management said the findings mark a critical step in proving […]
2 min read